Meyka Pro banner
SQZ Biotechnologies Company

SQZ Biotechnologies Company (SQZ) Stock Overview

Explore SQZ Biotechnologies Company’s financial performance, market position, analyst ratings, and future outlook.

SQZNYSE
HealthcareBiotechnology
$0.43
$0.16(61.11%)
U.S. Market opens in 16h 59m

SQZ Biotechnologies Company (SQZ)

Meyka AI Score

Z

Key Financials

Market Cap12.8M
P/E Ratio-0.16
EPS (TTM)$-2.16
ROE-0.86%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$1.98

SQZ Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of SQZ Biotechnologies Company (NYSE: SQZ) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, SQZ Biotechnologies Company's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SQZ on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $1.98 for the NYSE listing.

Key metrics behind SQZ Biotechnologies Company's NYSE-traded stock include a P/E ratio of -0.16 and a market capitalization of 12.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SQZ on the NYSE.

Price Performance (NYSE: SQZ)

1-Day Change
420.33%
5-Day Change
357.41%
1-Month Change
61.11%
3-Month Change
-26.27%
6-Month Change
-45.43%
Year-to-Date (YTD) Change
-41.22%
1-Year Change
-85.45%
3-Year Change
-96.72%
5-Year Change
-96.72%
All-Time (Max) Change
-96.72%

Contact Information

617 758 8672
200 Arsenal Yards Boulevard, Watertown, MA, 02472

Company Facts

530 Employees
IPO DateOct 30, 2020
CountryUS

Frequently Asked Questions